Hyperfine has announced the formation of its Neurosurgery Advisory Council, a multidisciplinary group of leading neurosurgeons who will provide expertise to help inform the potential role of portable ultra-low-field magnetic resonance imaging (MRI) in neurosurgical applications and shape the future of imaging in neurosurgical care.
“The neurosurgical setting is becoming an important site of care for accessible imaging, where traditional MRI has intrinsic limitations. The Swoop system [Hyperfine] may open up new possibilities for integrating imaging directly into surgical workflows,” said Hyperfine chief operating officer Tom Teisseyre. “Providing access to imaging at key moments around a procedure may help clinical teams make better-informed decisions, improve efficiency, and ultimately advance how surgical care is delivered.”
According to Hyperfine, the Neurosurgery Advisory Council brings together distinguished neurosurgeons from leading academic medical centres and community hospitals around the world, representing expertise in craniotomy, endovascular neurosurgery, transsphenoidal surgery, tumour resection, and other complex procedures. Together, these members will help to evaluate the potential role of the company’s US Food and Drug Administration (FDA)-cleared, artificial intelligence (AI)-powered Swoop system across the neurosurgical continuum—from preoperative planning and intraoperative decision-making to postoperative monitoring and discharge. The council will provide strategic clinical guidance on workflow integration, product development, and evidence generation, while sharing real-world experience that may help define best practices and expand the clinical utility of portable MRI across neurosurgical subspecialties.
The initial members of the council include Hakan Emmez (Güven Hospital, Ankara, Turkey), Brian Jankowitz (JFK University Medical Center, Edison, USA), Elad Levy (University at Buffalo Neurosurgery, Buffalo, USA), Gerald Michael Lemole Jr (Jefferson Abington Hospital/Thomas Jefferson University, Abington, USA), Debraj Mukherjee (Johns Hopkins Medical Institutions, Baltimore, USA), Todd Patrick (Christus Trinity Mother Frances Health System, Tyler, USA), Michael Schulder (Zucker School of Medicine at Hofstra/Northwell, Manhasset, USA), Adnan Siddiqui (Jacobs School of Medicine and Biomedical Sciences, Buffalo, USA), and Julian Spears (St Michael’s Hospital/University of Toronto, Toronto, Canada).
“The neurosurgical community has long recognised the value of intraoperative MRI, but access has been limited by the substantial infrastructure requirements, cost and workflow demands of having a high-field MRI system in the OR [operating room],” said Edmond Knopp, chief medical officer of Hyperfine. “Portable, ultra-low-field MRI has the potential to fundamentally change how and where imaging is used throughout the neurosurgical care pathway. Through collaboration with leading experts in the field, we aim to accelerate its integration into clinical practice and maximise its impact on surgical decision-making and patient care.”
